Is a
Other attributes
Member of Board of Directors of
Professor Tony Mok focuses on biomarker and molecular targeted therapy in lung cancer. He co-founded the Lung Cancer Research Group, and has led multiple multi-national studies that help establish the global standard on personalized medicine for lung cancer.
Timeline
No Timeline data yet.
Current Employer
Patents
Further Resources
No Further Resources data yet.
